Recruiting minority cancer patients into cancer clinical trials: A pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association
W. Mccaskill-stevens et al., Recruiting minority cancer patients into cancer clinical trials: A pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association, J CL ONCOL, 17(3), 1999, pp. 1029-1039
Purpose: Minority accrual onto clinical trials is of significant interest t
o cooperative oncology study groups. The Eastern Cooperative Oncology Group
(ECOG) conducted ct study to identify barriers and solutions to African Am
erican accrual onto clinical trials.
Methods: We hypothesize that the National Medical Association (NMA) might p
rovide insight into ways to increase minority participation and that ECOG m
ight facilitate that participation. Four sites were selected in which NMA c
hapters existed and ECOG main institutions with less than half of the corre
sponding percentage of minorities in their communities entered trials for 1
992, Fifteen workshops were conducted using discussions and open-ended, ser
f-administered questionnaires.
Results: Seventy percent of NMA physicians cited mistrust of the research c
enters, fear of losing patients, and a lack of respect from ECOG institutio
ns as the most important barriers to minority cancer patient referrals, com
pared with 30% for ECOG physicians. Sixty-nine percent of NMA and 43% of EC
OG physicians cited a lack of information about specific trials. Nearly hal
f of NMA physicians (47%) cited a lack of minority investigators as a barri
er, compared with 4% of ECOG physicians. Solutions by both groups were impr
oved communication (73%) and culturally relevant educational materials (40%
), ECOG physicians cited more minority outreach staff as a potential soluti
on (22% v 6%). NMA physicians cited increased involvement of referring phys
icians (44% v4%).
Conclusion: NMA physicians who serve a significant sector of the African Am
erican population demonstrated a willingness to participate and work with a
cooperative group effort to increase participation of minority patients an
d investigators. (C) 1999 by American Society of Clinical Oncology.